{"id":"NCT00363415","sponsor":"Eli Lilly and Company","briefTitle":"Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer","officialTitle":"A Randomized Phase 3 Trial of Alimta (Pemetrexed) and Carboplatin Versus Etoposide and Carboplatin in Extensive-Stage Small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-08","primaryCompletion":"2008-06","completion":"2008-06","firstPosted":"2006-08-15","resultsPosted":"2009-10-06","lastUpdate":"2009-10-28"},"enrollment":908,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"pemetrexed","otherNames":["LY231514","Alimta"]},{"type":"DRUG","name":"etoposide","otherNames":[]},{"type":"DRUG","name":"carboplatin","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"ACTIVE_COMPARATOR"}],"summary":"This study is a Phase 3, global, multi-center, open-label study of patients with extensive-stage small cell lung cancer. Eligible patients will be randomly assigned to receive either pemetrexed plus carboplatin or etoposide plus carboplatin. It is anticipated that pemetrexed plus carboplatin will offer similar survival benefits as compared to etoposide plus carboplatin.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"baseline to date of death from any cause (up to 19.6 months)","effectByArm":[{"arm":"Pemetrexed + Carboplatin","deltaMin":8.1,"sd":null},{"arm":"Etoposide + Carboplatin","deltaMin":10.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.01"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":189,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","China","France","Germany","Greece","Hungary","India","Italy","Netherlands","New Zealand","Poland","Portugal","Puerto Rico","Romania","Russia","South Africa","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["36184621","19720897"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":150},"commonTop":["Cough","Dyspnoea","Hypertension","Fatigue","Neutropenia"]}}